2021
DOI: 10.1016/j.remnie.2020.08.002
|View full text |Cite
|
Sign up to set email alerts
|

Assessment of a well-differentiated pancreatic neuroendocrine tumor with 68Ga-DOTATOC PET/CT, 68Ga-DOTATOC PET/MRI and 99mTc-octreotide SPECT/CT. What does each scan provide?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 1 publication
0
1
0
Order By: Relevance
“…Gastro-entero-pancreatic NET primarily metastasize to the mesenteric lymph nodes and to the liver. The evaluation/characterization of liver metastases from NET should rely on a somatostatin receptor targeting radiopharmaceutical [136][137][138]. Indeed, SSTR-PET/MRI incorporating hepatobiliary phase imaging is a useful modality in patients with liver dominant NET.…”
Section: Neuroendocrine Tumorsmentioning
confidence: 99%
“…Gastro-entero-pancreatic NET primarily metastasize to the mesenteric lymph nodes and to the liver. The evaluation/characterization of liver metastases from NET should rely on a somatostatin receptor targeting radiopharmaceutical [136][137][138]. Indeed, SSTR-PET/MRI incorporating hepatobiliary phase imaging is a useful modality in patients with liver dominant NET.…”
Section: Neuroendocrine Tumorsmentioning
confidence: 99%